Lewis Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Lewis Asset Management's ABBV Position: Q3 2026 in Review
Lewis Asset Management reduced its AbbVie (ABBV) stake by 1.9% in Q3 2026, selling an estimated $78.2K and leaving 15,890 shares worth $4.16M. The position accounts for 1.42% of the portfolio, ranked #14.
Lewis Asset Management first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 4,015 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Lewis Asset Management held 15,890 shares of AbbVie worth $4.16M as of Q3 2026.
- Lewis Asset Management sold 305 AbbVie shares in Q3 2026, an estimated $78.2K.
- AbbVie made up 1.42% of Lewis Asset Management's portfolio in Q3 2026, its #14 holding.
- Lewis Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
- 4,015 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Lewis Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.